Edgewise Therapeutics's chart data is dated 2026-10-09. There is no active technical signal. There are 7 published signal records.
Edgewise Therapeutics last closed at $39.06 (-0.43%) on 2026-10-09. Listed on Nasdaq. Trailing 12 months PER is -21.4×. Its overall grade ranks 156 of 738 stocks in Healthcare.
About this company
Edgewise Therapeutics last closed at $39.06 (-0.43%) on 2026-10-09. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall A- · 156/738
Valuation grade A+
Related stocks
- Vertex PharmaceuticalsCompetitor
근육질환·희귀질환 영역에서 경쟁하는 대형 바이오 기업
- Sarepta TherapeuticsCompetitor
DMD 등 근육질환 치료제 개발에서 직접 경쟁
- PfizerCompetitor
희귀질환·근육질환 파이프라인 경쟁 가능성이 있는 대형 제약사
ETFs holding this stock
ALPS Medical Breakthroughs ETF
Details →About Edgewise Therapeutics
- What technical signals does Edgewise Therapeutics (EWTX) have?
- Edgewise Therapeutics current technical signals: no active technical signal.
- Is Edgewise Therapeutics a cup-and-handle pattern?
- No. Edgewise Therapeutics has no valid Cup signal right now.
- What published figures are available for Edgewise Therapeutics?
- Market cap: $4.14B. Trailing 12 months PER: -21.4×. Latest quarter PBR: 9.43×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about Edgewise Therapeutics, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.